- ￥1800
- Biorigin
- BN42150R
- 2025年08月17日
- IHC-P,
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 应用范围：
IHC-P,
- 抗体英文名：
CD163
- 规格：
50ul
| 英文名称 | CD163 |
| 中文名称 | CD163重组兔单克隆抗体 |
| 别 名 | Scavenger receptor cysteine-rich type 1 protein M130; CD 163; CD163 antigen; CD163 molecule; Hemoglobin Scavenger Receptor; M130; M130 antigen precursor; Macrophage associated antigen; MM130; C163A_HUMAN. |
| 研究领域 | 心血管 免疫学 细胞膜受体 |
| 抗体来源 | Rabbit |
| 克隆类型 | Monoclonal |
| 克 隆 号 | 8G1 |
| 交叉反应 | Human, |
| 产品应用 | WB=1:500-2000 IP=1:20-100 IHC-P=1:50-200 IHC-F=1:50-200 Flow-Cyt=1:50 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 130kDa |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human CD163: |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| PubMed | PubMed |
| 产品介绍 | CD163 is a 130 kDa membrane glycoprotein. It is a member of the scavenger receptor cysteine-rich superfamily and is a receptor for the hemoglobin-haptoglobin complex. CD163 is expressed exclusively on the cell surface of human monocytes and macrophages that evolve predominantly in the late phase of inflammation. CD163 is present on all CD14 positive monocytes, most CD64 positive monocytes, and shows higher expression on CD16 positive monocytes. CD163 is upregulated on mononuclear phagocytes by IL-10, IL-6 and dexamethasone. Lipopolysaccharide (LPS) and phorbol myristate acetate (PMa) both induce shedding of CD163 from the cell surface into plasma or cell supernatant. Function: Acute phase-regulated receptor involved in clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages and may thereby protect tissues from free hemoglobin-mediated oxidative damage. May play a role in the uptake and recycling of iron, via endocytosis of hemoglobin/haptoglobin and subsequent breakdown of heme. Binds hemoglobin/haptoglobin complexes in a calcium-dependent and pH-dependent manner. Exhibits a higher affinity for complexes of hemoglobin and multimeric haptoglobin of HP*1F phenotype than for complexes of hemoglobin and dimeric haptoglobin of HP*1S phenotype. Induces a cascade of intracellular signals that involves tyrosine kinase-dependent calcium mobilization, inositol triphosphate production and secretion of IL6 and CSF1. Isoform 3 exhibits the higher capacity for ligand endocytosis and the more pronounced surface expression when expressed in cells. Subcellular Location: Secreted and Cell membrane. Isoform 1 and isoform 2 show a lower surface expression when expressed in cells. Tissue Specificity: Expressed in monocytes and mature macrophages such as Kupffer cells in the liver, red pulp macrophages in the spleen, cortical macrophages in the thymus, resident bone marrow macrophages and meningeal macrophages of the central nervous system. Expressed also in blood. Isoform 1 is the lowest abundant in the blood. Isoform 2 is the lowest abundant in the liver and the spleen. Isoform 3 is the predominant isoform detected in the blood. Post-translational modifications: A soluble form (sCD163) is produced by proteolytic shedding which can be induced by lipopolysaccharide, phorbol ester and Fc region of immunoglobulin gamma. This cleavage is dependent on protein kinase C and tyrosine kinases and can be blocked by protease inhibitors. The shedding is inhibited by the tissue inhibitor of metalloproteinase TIMP3, and thus probably induced by membrane-bound metalloproteinases ADAMs. Phosphorylated. Similarity: Contains 9 SRCR domains. SWISS: Q86VB7 Gene ID: 9332 Database links: Entrez Gene: 9332 Human Omim: 605545 Human SwissProt: Q86VB7 Human Unigene: 504641 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验DimAb®重组单克隆抗体开发平台 缔码生物拥有独创的DimAb®重组单克隆抗体开发平台，可以在完成动物免疫后直接从外周血中获取阳性B细胞并克隆抗体基因序列。从单只免疫动物中我们可以得到上千个靶点结合阳性B细胞克隆，从中我们能够更为高效的筛选出具有高特异性，高灵敏度，和高亲和力重组单克隆抗体。 1. DimAb®平台流程 2. DimAb®平台优势 3. DimAb®与其它抗体开发平台比较 B细胞抗体开发平台可成药性更高 一个新开发的先导抗体分子最终能否成药，会
相关专题 层析柱的类型及作用 重组 人α干扰素作为一种具有广谱抗病毒、抑制肿瘤细胞生长及免疫调节作用的细胞因子新型药物，已在国内外广泛投入临床应用，并取得了显著的疗效。国际上对用于临床的重组干扰素的纯度要求很高，美国NIH规定必须在90%以上,因此生产者普遍采用亲和层析纯化法。我们研制了rHuIFN-α2a的McAb 3F1,与CNBr活化的Sepharose 4B交联制成亲和层析柱,经1年60余次较大规模试用
单克隆抗体(McAb)亲和层析柱纯化重组人α2a干扰素(rHuIFN-α2a)
重组人α干扰素作为一种具有广谱抗病毒、抑制肿瘤细胞生长及免疫调节作用的 细胞因子 新型药物，已在国内外广泛投入临床应用，并取得了显著的疗效。国际上对用于临床的重组干扰素的纯度要求很高，美国NIH规定必须在90％以上,因此生产者普遍采用亲和层析纯化法。我们研制了rHuIFN-α2a的McAb 3F1,与CNBr活化的Sepharose 4B交联制成亲和层析柱,经1年60余次较大规模试用表明具有较理想的亲和层析纯化rHuIFN-α2a的性能，达到
技术资料暂无技术资料 索取技术资料
